Attorneys for the government and drug manufacturer Eli Lilly dueled over the legality of 340B contract pharmacy requirements during a hearing before a federal district judge in Indianapolis today.
Stakeholders are watching the Lilly case closely because, given how far along the case is in the legal process, U.S. District Judge Sarah Evans Barker could be the first judge to rule on one of the six 340B violation letters HRSA sent to manufacturers in May.
Attorneys for the government and drug manufacturer Eli Lilly dueled over legality of 340B contract pharmacy requirements during a hearing before a federal district judge in Indianapolis today.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
